Live feed
Filing
SC 13G
SC 13G0000846087-23-000198·WELLINGTON MANAGEMENT GROUP LLP
Schedule 13G ownership disclosure
Zentalis Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 98943L107
Event date: 2022-12-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,618,493
- Percent of class
- 6.3400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000846087-23-000198
- Form type
- SC 13G
- Filer
- WELLINGTON MANAGEMENT GROUP LLP
- CIK
- CIK 902219
- Filed
- Feb 06, 2023
- Reporting period
- Dec 30, 2022
- Description
- Schedule 13G beneficial ownership